Emmaus Life Sciences
Stock Forecast, Prediction & Price Target
Emmaus Life Sciences Financial Estimates
Emmaus Life Sciences Revenue Estimates
Emmaus Life Sciences EBITDA Estimates
Emmaus Life Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $20.61M N/A | $18.39M -10.77% | $29.59M 60.94% | Avg: $30.14M Low: $30.14M High: $30.14M avg. 1.86% | |||
Net Income
% change YoY
| $-15.94M N/A | $-10.68M 32.99% | $-3.73M 65.06% | Avg: $2.96M Low: $2.96M High: $2.96M avg. 179.46% | |||
EBITDA
% change YoY
| $-8.04M N/A | $-6.58M 18.09% | $3.57M 154.23% | Avg: $-12.70M Low: $-12.70M High: $-12.70M avg. -455.78% | |||
EPS
% change YoY
| -$0.32 N/A | -$0.22 31.25% | -$0.07 68.04% | Avg: $0.06 Low: $0.06 High: $0.06 avg. 185.34% | |||
Operating Expenses
% change YoY
| $23.42M N/A | $22.38M -4.43% | $24.71M 10.39% | Avg: $66.48M Low: $66.48M High: $66.48M avg. 169.02% | |||
FAQ
What is Emmaus Life Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 179.46% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is 2.96M, average is 2.96M and high is 2.96M.
What is Emmaus Life Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1.86% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $30.14M, average is $30.14M and high is $30.14M.
What is Emmaus Life Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 185.34% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.06, average is $0.06 and high is $0.06.